e-learning
resources
Munich 2006
Sunday 03.09.2006
Clinical features of interstitial lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Organizing pneumonia – characteristics of 37 patients
E. Radzikowska, E. Wiatr, R. Langfort, I. Bestry, P. Remiszewski, K. Roszkowski (Warsaw, Poland)
Source:
Annual Congress 2006 - Clinical features of interstitial lung disease
Session:
Clinical features of interstitial lung disease
Session type:
Electronic Poster Discussion
Number:
1772
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Radzikowska, E. Wiatr, R. Langfort, I. Bestry, P. Remiszewski, K. Roszkowski (Warsaw, Poland). Organizing pneumonia – characteristics of 37 patients. Eur Respir J 2006; 28: Suppl. 50, 1772
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Clinical analysis of 25 subjects with biopsy-proven cryptogenic organizing pneumonia
Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Year: 2007
Clinical features of COVID-19 pneumonia in elderly patients
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Clinical feature of Japanese patients with healthcare-associated pneumonia
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Clinical characteristics of the patients with community-acquired Legionella pneumonia in advanced age
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005
Characteristics of hospitalized COVID-19 patients and parameters associated with severe pneumonia
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Characteristics of secondary pneumonias in patients who died at home
Source: Eur Respir J 2002; 20: Suppl. 38, 444s
Year: 2002
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Bacterial features of bacteremia in pediatric patients with pneumonia at Children hospital No. 1, Vietnam
Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others
Year: 2019
Risk contribution of comorbidities in hospitalized patients with Covid 19 pneumonia
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Etiology of community-acquired pneumonia (CAP) in young hospital patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Management of community-acquired pneumonia in adult outpatients
Source: Eur Respir J 2006; 28: Suppl. 50, 377s
Year: 2006
Biological markers in hospitalised patients with community acquired pneumonia (CAP)
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Prior antibiotics and outcomes in patients hospitalized with pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Clinical features of cryptogenic organizing pneumonia in a Chilean population
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Comparative analysis of clinical and epidemiological characteristics of patients with CAP (community-acquired pneumonia) treated as inpatients and outpatients
Source: Eur Respir J 2006; 28: Suppl. 50, 3s
Year: 2006
Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept